Nitya Nathwani

Suggest Changes
  • Citations Per Year
Learn More
Allogeneic hematopoietic stem cell transplantation (alloHCT) is offered increasingly to elderly patients with hematologic malignancies. However, outcome data in those who are 70 years or older are(More)